Portola Pharmaceuticals ( PTLA) is a biopharmaceutical company that develops and commercializes novel therapeutics in the areas of thrombosis, other hematologic disorders and inflammation for patients who currently have limited or no approved treatment options. This stock closed up 3.3% at $27.03 in Monday's trading session.
Monday's Volume: 130,000
Three-Month Average Volume: 109,412
Volume % Change: 65%
Twitter and become a fan on Facebook.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts